The molecular mechanisms by which these natural products influence the Hippo/YAP pathway are highlighted, potentially leading to reduced tumor growth, apoptosis induction, and improved treatment outcomes when used in combination with conventional cancer therapies. This evidence concerns the gene YAP1 and neoplasm.